Cath Lab

The cardiac catheterization laboratory is used for diagnostic angiograms and percutaneous coronary interventions (PCI). Cath labs have also seen expanding use in recent years for transcatheter structural heart procedures. Some hospitals also share these labs with other subspecialties for catheter-based procedures in electrophysiology (EP), interventional radiology, peripheral artery disease (PAD), carotid and neuro interventional procedures and vascular surgery.

FDA clears next-gen hybrid system for intravascular imaging
Conavi Medical's new hybrid imaging system simultaneously performs IVUS and OCT.
Stereotaxis to acquire robotic PCI company Robocath for up to $45M
The deal includes an upfront payment of $20 million. Stereotaxis could pay up to an additional $25 million if certain regulatory and commercial milestones are met.
FDA clears next-gen device for left-heart access
Early data linked the device with short crossing times, reduced fluoro exposure and no device-related adverse events.
Heartflow sues cardiology AI rival Cleerly over alleged patent infringement
According to Heartflow, Cleerly's actions represent “one of the most egregious examples of piracy in the medical technology industry.” Cleerly commented on the lawsuit, defending the value and integrity of its products.
FDA shares warning about cath lab procedure kits due to risk of patient injury
The syringes included in several convenience kits should not be used due to a safety risk linked to multiple injuries.

FDA clears next-gen hybrid system for intravascular imaging

Conavi Medical's new hybrid imaging system simultaneously performs IVUS and OCT.

Stereotaxis to acquire robotic PCI company Robocath for up to $45M

The deal includes an upfront payment of $20 million. Stereotaxis could pay up to an additional $25 million if certain regulatory and commercial milestones are met.

FDA clears next-gen device for left-heart access

Early data linked the device with short crossing times, reduced fluoro exposure and no device-related adverse events.

Heartflow sues cardiology AI rival Cleerly over alleged patent infringement

According to Heartflow, Cleerly's actions represent “one of the most egregious examples of piracy in the medical technology industry.” Cleerly commented on the lawsuit, defending the value and integrity of its products.

FDA shares warning about cath lab procedure kits due to risk of patient injury

The syringes included in several convenience kits should not be used due to a safety risk linked to multiple injuries.

Beacon Tip Centimeter Sizing Catheter FDA alert

FDA warns that certain sizing catheters should not be used due to risk of breaking

These catheters from Cook Medical are associated with an increased risk of device fragmentation or vessel injury. Customers are urged to return them to the manufacturer.

warning safety alert recall healthcare issue

Medline recalls millions of devices due to safety risk—FDA threatens ‘regulatory action’ in warning letter

Millions of angiographic syringes were recalled due to a risk of parts becoming loose or disconnected. The FDA, unhappy with Medline's response to this situation, sent the company a new warning letter.

‘Practice-changing’ interventional cardiology research grabs ACC.26 spotlight

The second day of the American College of Cardiology’s annual conference started with a series of highly anticipated interventional cardiology trials.